2022 Annual Meeting of the NCI Cohort Consortium (Agenda) | Events Registration

Agenda

Download Agenda

Day 1, Tuesday, November 1, 2022 (8:00–11:45 a.m. ET)

8:00–8:40	Watch this Session Opening Remarks and Acknowledgements Dr. Kathy Helzlsouer, National Cancer Institute, NIH Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health Welcoming Remarks from the National Cancer Institute Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH Dr. Stephen Chanock, Director, Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH Dr. Emily Tonorezos, Director, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH
8:40–9:45	SESSION I: DATA SHARING Watch this Session
	Moderators: Dr. Kathy Helzlsouer, National Cancer Institute, NIH Dr. Jessica Petrick, Slone Epidemiology Center at Boston University
8:40–9:05	NIH Data Sharing Policy Update Dr. Julia Slutsman, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH Dr. Nonye Harvey, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH Q & A Session
9:05–9:25	Advances in Data Science from the NIH perspective Dr. Susan Gregurick, Office of Data Science Strategy, NIH Q & A Session
9:25–9:45	Virtual Pooled Registry Cancer Linkage System: Current and Future Initiatives Ms. Castine Clerkin, North American Association of Central Cancer Registries Q & A Session
9:45–10:00	Break
10:00–11:30	SESSION II: CHALLENGES AND OPPORTUNITIES FOR COHORTS OF CANCER SURVIVORS Watch this Session
	Moderators: Dr. Joanne Elena, National Cancer Institute, NIH Dr. Traci Bethea, Georgetown Lombardi Comprehensive Cancer Center
10:00–11:00	Cohort Overview Lymphoma Epidemiology of Outcomes (LEO) Cohort Dr. James Cerhan, Mayo Clinic College of Medicine and Science England & Wales Hodgkin Lymphoma Cohort Dr. Aislinn Macklin-Doherty, The Royal Marsden NHS Foundation Trust ColoCare Consortium (ColoCare) Dr. Neli Ulrich, Comprehensive Cancer Center at Huntsman Cancer Institute Pathways Study Dr. Larry Kushi, Kaiser Permanente Northern California Susan G. Komen Tissue Bank Updates from the Director Dr. Michele Cote, Indiana University Simon Comprehensive Cancer Center
11:00–11:30	Panel Discussion
11:30–11:45	Associate Member Council Update Dr. Lauren E. McCullough, Emory University
11:45	Adjourn
12:00–12:45	Networking Session Hosted by Early Career Scientists (optional)

Day 2, Wednesday, November 2, 2022 (1:00–5:00 p.m. ET)

12:00–12:45	General Networking Session (optional)
1:00–1:05	Watch this Session Opening Remarks Dr. Kathy Helzlsouer, National Cancer Institute, NIH
1:05–1:45	Plenary Session - State of the Science in Survivorship Research Dr. Patricia A. Ganz, UCLA School of Medicine and Public Health and UCLA Jonsson Comprehensive Cancer Center
1:45–2:00	Q & A Session
2:00–3:15	SESSION III: DATA COLLECTION, ACCESS, AND LINKAGES
	Moderators: Dr. Erika Rees-Punia, American Cancer Society Dr. Mia Gaudet, National Cancer Institute, NIH
2:00–2:20	Perspectives on CMS linkage for Cancer Research in Cohort Studies Dr. Lynne R. Wilkens, University of Hawaii Cancer Center Dr. Janet Olson, Mayo Clinic College of Medicine
2:20–2:35	Q & A Session
2:35–3:05	*The All of Us* Research Program- Data Types, Data Access, Data Analysis** Dr. Sheri Schully, All of Us Research Program, NIH
3:05–3:15	Q & A Session
3:15–3:35	Research Facilitation Report Dr. Roger Milne, Cancer Council Victoria
3:35–3:50	Break
3:50–4:50	SESSION IV: COHORT CONSORTIUM PROJECT GROUP REPORT BACKS Watch this Session
	Moderators: Dr. Jeannette Schenk, Fred Hutchinson Cancer Research Center Dr. Melissa Merritt, The University of Sydney Sexual and Gender Minority Interest Group Dr. Sarah S. Jackson, National Cancer Institute, NIH The Breast Cancer Risk Prediction Project Dr. Peter Kraft, Harvard T.H. Chan School of Public Health Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer Dr. Konrad Stopsack, Harvard T.H. Chan School of Public Health Dr. Eboneé Butler, University of North Carolina Lung Cancer Cohort Consortium (LC3) Dr. Mattias Johansson, International Agency for Research Cancer Linkage of NCI Cohort Consortium Projects Dr. Jessica Petrick, Slone Epidemiology Center at Boston University Investigating the role of immune markers in driving sex-specific differences in Glioblastoma (GBM) development Dr. Kristin Waite, National Cancer Institute, NIH
4:50	Closing Remarks and Adjourn Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health